India to Tanzania: Amoxicillin Export Trade Route
India has recorded 509 verified shipments of Amoxicillin exported to Tanzania, representing a combined trade value of $19.7M USD. This corridor is served by 58 active Indian exporters, with an average shipment value of $38.7K USD. The leading Indian exporter is SPARSH BIO-TECH PRIVATE LIMITED, which accounts for 28% of total export value with 125 shipments worth $5.4M USD. On the buying side, SPARSH BIO-TECH HEALTHCARE PVT. LTD is the largest importer in Tanzania with $1.9M USD in purchases. The top 3 suppliers — SPARSH BIO-TECH PRIVATE LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, MEDOPHARM PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Tanzania Amoxicillin corridor is one of India's established pharmaceutical export routes, with 509 shipments documented worth a combined $19.7M USD. The route is dominated by SPARSH BIO-TECH PRIVATE LIMITED, which alone accounts for roughly 28% of all export value, reflecting the consolidated nature of India's amoxicillin manufacturing sector.
Across 58 active suppliers, the average shipment value stands at $38.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with amoxicillin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 16.3%, placing it at rank #5 among India's top amoxicillin export destinations globally.
On the import side, key buyers of Indian amoxicillin in Tanzania include SPARSH BIO-TECH HEALTHCARE PVT. LTD, SPARSH BIO-TECH HEALTHCARE PVT LTD, MEDICAL STORES DEPARTMENT and 95 others. SPARSH BIO-TECH HEALTHCARE PVT. LTD is the single largest importer with 21 shipments valued at $1.9M USD.
